Wikidata

(Q65334516)

English

Phase 3 Randomized, Double-blind, Controlled Study of ICT-107 in Glioblastoma

clinical trial

In more languages

Statements

title
A Phase 3 Randomized Double-blind, Controlled Study of ICT-107 With Maintenance Temozolomide (TMZ) in Newly Diagnosed Glioblastoma Following Resection and Concomitant TMZ Chemoradiotherapy (English)
0 references
country
Austria
0 references
Canada
0 references
start time
December 2015
0 references
end time
December 2019
0 references
number of participants
414
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q65334516&oldid=1858148475"